OpenAI hasn’t formally committed to an IPO, but CEO Sam Altman, in a livestream broadcast discussing the new structure, said ...

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company ...

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Navan is perhaps the most high-profile IPO over the past month, as the SEC's filing process has stalled with 90% of staff furloughed.

OpenAI is preparing for a $1 trillion IPO that could launch in 2026. The ChatGPT maker plans to raise at least $60 billion ...

Initial public offerings are selling like hot concert tickets, soaring in value from their original price. Investors were watching to see if StubHub, the popular marketplace for ticket resales, would ...

The IPO preparations follow a restructuring of OpenAI completed on October 28 that reduced the company’s reliance on ...

Medline disclosed on Tuesday that its revenue rose 9.7% in the first half of 2025, as one of the world's largest makers of ...

Corporate travel and expense management firm Navan Inc. (NASDAQ: NAVN) burst onto the public markets this week, raising about ...

Investors who missed out on Palantir might be shocked to see how much of a winner the stock has been over the last ...

The trajectory of the Lenskart IPO GMP shows how exuberance has given way to caution, with the market asking for a bit more ...

Live Updates Live Coverage Has Ended Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get ...